Sign in
Taking people in United StatesNo phase

Pervasive Sensing and AI in Intelligent ICU

Key facts

Who runs it
University of Florida
Where
Gainesville, United StatesSee the site
Trial code
Status
Recruiting
People taking part
400 people, planned
Started
24 May 2021
Expected to end
Dec 2026
Type of study
Observational
Treatments tested
  • Video Monitoring
  • Accelerometer Monitoring
  • Noise Level Monitoring
  • Light Level Monitoring
  • Air Quality Monitoring
  • EKG Monitoring
  • Vitals Monitoring
  • Biosample Collection
  • Delirium Motor Subtyping Scale 4 (DMSS-4)
Record updated
6 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (7)Hide the full registry criteria

Who can take part

  • aged 18 or older
  • admitted to UF Health Shands Gainesville ICU ward
  • expected to remain in ICU ward for at least 24 hours at time of screening

Who cannot take part

  • under the age of 18
  • on any contact/isolation precautions
  • expected to transfer or discharge from the ICU in 24 hours or less
  • unable to provide self-consent or has no available proxy/LAR

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age

This trial is currently available in United States.

  • University of Florida Health Shands HospitalGainesville, United StatesContact: Andrea Davidson, BSTaking people

About the trial

What the trial wants to find out

Important information related to the visual assessment of patients, such as facial expressions, head and extremity movements, posture, and mobility are captured sporadically by overburdened nurses, or are not captured at all. Consequently, these important visual cues, although associated with critical indices such as physical functioning, pain, delirious state, and impending clinical deterioration, often cannot be incorporated into clinical status. The overall objectives of this project are to sense, quantify, and communicate patients' clinical conditions in an autonomous and precise manner, and develop a pervasive intelligent sensing system that combines deep learning algorithms with continuous data from inertial, color, and depth image sensors for autonomous visual assessment of critically ill patients. The central hypothesis is that deep learning models will be superior to existing acuity clinical scores by predicting acuity in a dynamic, precise, and interpretable manner, using autonomous assessment of pain, emotional distress, and physical function, together with clinical and physiologic data.

The group in the trial

  • adult ICU patients

    adult patients aged 18 or older admitted to University of Florida Health Shands Gainesville ICU wards

    Treatment: Video Monitoring, Accelerometer Monitoring, Noise Level Monitoring, Light Level Monitoring, Air Quality Monitoring, EKG Monitoring, Vitals Monitoring, Biosample Collection, and Delirium Motor Subtyping Scale 4 (DMSS-4)

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 1 eligibility question with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Pervasive Sensing and Artificial Intelligence in Intelligent ICU Subtitles: -Intelligent Intensive Care Unit (I2CU): Pervasive Sensing and Artificial Intelligence for Augmented Clinical Decision-making -ADAPT: Autonomous Delirium Monitoring and Adaptive Prevention
Criteria questions
Built from NCT05127265, who can take part
Record updated
6 July 2026